LycoRed Ltd.
13
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
15.4%
2 terminated/withdrawn out of 13 trials
84.6%
-1.9% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Astaxanthin, Exercise Inflammation, Skin Health
Role: collaborator
A Study to Evaluate the Effect of Astaxanthin in Healthy Participants
Role: lead
A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
Role: lead
A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants.
Role: lead
A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects
Role: lead
Lumenato Nutritional Supplement on Skin Appearance
Role: lead
Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)
Role: lead
Evaluation of the Nutritional Supplement Lycoderm on Its Impact on Skin Parameters
Role: lead
The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow
Role: lead
Effect of Tomato Extracted Lycopene on Postprandial Oxidation and inflammation in Healthy Weight Men and Women
Role: lead
Effect of Cardio Mato (Grade A Lyc-O-Mato, a Tomato Extracted Lycopene) on Blood Pressure
Role: lead
LycoRed 40051 Product as a Countermeasure to Exercise Stress
Role: collaborator
Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects
Role: collaborator
All 13 trials loaded